Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-54,874
Closed -$13M 292
2021
Q2
$13M Sell
54,874
-52,938
-49% -$12.1M 0.56% 62
2021
Q1
$23.6M Sell
107,812
-28,418
-21% -$5.7M 0.83% 27
2020
Q4
$23.8M Sell
136,230
-5,517
-4% -$953K 0.72% 30
2020
Q3
$22.9M Buy
141,747
+130,456
+1,155% +$20.7M 0.56% 43
2020
Q2
$1.61M Sell
11,291
-16,645
-60% -$2.3M 0.06% 327
2020
Q1
$3.04M Buy
27,936
+16,180
+138% +$2.33M 0.13% 168
2019
Q4
$1.71M Hold
11,756
0.06% 329
2019
Q3
$1.7M Buy
11,756
+349
+3% +$50.9K 0.06% 319
2019
Q2
$1.69M Buy
+11,407
New +$1.59M 0.06% 322
2018
Q4
Sell
-14,434
Closed -$2.15M 466
2018
Q3
$2.15M Hold
14,434
0.07% 298
2018
Q2
$2.23M Hold
14,434
0.07% 294
2018
Q1
$2.01M Hold
14,434
0.07% 300
2017
Q4
$1.98M Hold
14,434
0.07% 295
2017
Q3
$1.87M Hold
14,434
0.07% 303
2017
Q2
$1.91M Hold
14,434
0.07% 295
2017
Q1
$1.78M Sell
14,434
-698
-5% -$82.6K 0.07% 307
2016
Q4
$1.67M Hold
15,132
0.06% 330
2016
Q3
$1.79M Buy
+15,132
New +$1.78M 0.07% 300

Other funds holding LH

BP's LH Position: Q3 2021 in Review

BP sold out of Labcorp (LH) in Q3 2021, closing a stake of 54,874 shares — an estimated $13M sold.

BP first reported a position in LH in Q3 2016 and held it in 18 quarters. The position peaked at $23.8M in Q4 2020. 993 funds tracked by Wall St. Rank hold LH as of Q3 2021.

  • BP reported no remaining Labcorp position as of Q3 2021 after selling out during the quarter.
  • BP sold 54,874 Labcorp shares in Q3 2021, an estimated $13M.
  • BP first reported a position in Labcorp in Q3 2016 and held it in 18 quarters.
  • BP's Labcorp position peaked at $23.8M in Q4 2020.
  • 993 funds tracked by Wall St. Rank held Labcorp as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.